Salubrent Pharma Solutions Strengthens Analytical Team

Annad Padmanabhan and Maggie Thomasson will fill key roles at Salubrent’s new cGMP analytical laboratory in Kannapolis, NC.

Salubrent announced that they had filled two positions at the company’s recently opened cGMP analytical laboratory in Kannapolis, NC on Dec. 7, 2021. Annad Padmanabhan will join as Director of Analytical Development, while Maggie Thomasson will fill the role of Analytical Development Chemist.

Padmanabhan brings more than 29 years of experience in analytical R&D and quality control; in particular, he specializes in analytical method development and method validation. He has previously worked with Glenmark Pharmaceuticals, G&W Laboratories, Ei LLC, and Applied Analytical Industries, among others.

Thomasson brings more than five years of method development and validation experience with high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, cell culture/lysis, and protein expression. Thomasson has a deep understanding of many safety and regulatory compliance guidelines. She has worked with Sentia Wellness and Pfizer (Aerotek).

“Adding these two seasoned experts to our team is representative of our commitment to providing the Salubrent customer experience to customers in need of comprehensive analytical testing services, including stability program management,” said Terry Novak, president & CEO of Salubrent Pharma Solutions, in a company press release. “The new hires allow Salubrent to fully utilize its new analytical lab and further extend the expertise, experience, and capabilities that we bring to our customers.”

Source: Salubrent